The 26th webinar of the European Stroke Organisation’s educational series focused on the critical topic, “When the weather strikes: understanding stroke risk in the era of climate extremes”. Moderated by Dr Marieta Peycheva and Dr Vojtech Novotny, the session was delivered by two expert neurologists.
The first speaker, Dr. Vasileios Tentolouris Piperas (from the National and Kapodistrian University of Athens, Greece), presented evidence linking air pollution and wildfires to increased stroke risk. Climate change, defined as a long-term shift in average weather patterns, is contributing to an increase in intense and destructive wildfires. In Europe alone, approximately 1 million hectares were burned in 2025 up to October 28th, an area equivalent to Montenegro. Wildfires are significant sources of pollution, as well as the energy production industry and the urban traffic. One of the main air pollutants is the Particulate Matter (PM) 2.5, extremely small particles associated with cerebrovascular risk. The talk highlighted that outdoor air pollution is now recognised as the second most important modifiable risk factor globally for stroke-related disability, according to the 2025 World Stroke Organisation fact sheet. Epidemiological data confirms that exposure to wildfires or high PM 2.5 concentrations leads to a short-term rise in cerebrovascular events, especially within the first few days and among adults over 65. Long-term exposure also increases stroke incidence and mortality. The mechanisms involve the activation of sensory receptors in the respiratory system, leading to a sympathetic response (vasospasm/arrhythmias); an inflammatory response causing oxidative stress and hypercoagulable states; and the potential translocation of particles that contribute to platelet aggregation and atherosclerotic plaque formation. It was suggested that future interventions should focus on reducing pollution in high-risk areas globally, such as South Asia and Northern Africa, but also monitor susceptible areas in Europe, like the Mediterranean and the Balkans.
The second speaker, Professor Anita Arsovska (from the University Clinic of Neurology, University Ss Cyril and Methodius in Skopje, North Macedonia), discussed how ambient temperature extremes and rapid fluctuations affect stroke occurrence, defining climate change as a fundamental threat to human health. Research consistently links both high and low temperatures to increased stroke events, though the pattern differs by stroke subtype. Ischemic stroke risk peaks during warmer months and is associated with heat extremes and heat waves, with effects often immediate, occurring within the first four days. In contrast, intracerebral hemorrhage shows a stronger association with cold temperatures. The effects of cold often exhibit a longer lag, extending up to 30 days, reflecting delayed consequences of cold-induced blood pressure changes. Rapid temperature fluctuations (e.g., changes between 5 and 8 degrees Celsius) also increase stroke risk. Pathophysiologically, extreme cold triggers vasoconstriction and hypertension, increasing hemorrhagic risk, while extreme heat leads to dehydration and hypercoagulable states, increasing ischemic risk. The elderly and those with comorbidities like heart failure are highly vulnerable. It was proposed that public health strategies should include early warning systems using machine learning models combined with weather data to forecast high-risk days and enhance hospital preparedness. Furthermore, incorporating temperature risk into discharge planning and patient counseling is crucial.
Finally, during the Q&A session, the speakers agreed that incorporating climate-related risk factors into professional education and national registries is an essential next step for the stroke community.
Learn more about our Educational Webinars: ESO Educational Webinars -European Stroke Organisatoin
ESOC is Europe’s leading forum for advances in research and clinical care of patients with cerebrovascular diseases. ESOC 2026 will live up to its expectation, and present to you a packed, high quality scientific programme including major clinical trials, state-of-the-art seminars, educational workshops, scientific communications of the latest research, and debates about current controversies. Learn more.


